COVID antibody treatments show promise for preventing severe disease

Heidi Ledford

Nature, 2021, vol. 591, issue 7851, 513-514

Abstract: But uptake by patients and physicians has been low in the United States, where some therapies have been authorized for months.

Keywords: Virology; Immunology; SARS-CoV-2 (search for similar items in EconPapers)
Date: 2021
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-021-00650-7 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:591:y:2021:i:7851:d:10.1038_d41586-021-00650-7

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-021-00650-7

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().